PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 460: Patients' Access to Treatments Act of 2013

Before you vote › Federal bills

H.R. 460: Patients' Access to Treatments Act of 2013

113th Congress · introduced 2013-02-04 · Health · Latest: Referred to the Subcommittee on Health.

federal

Follow this bill, step by step

  1. Where it came from: introduced 2013-02-04 · official record
  2. Who proposed it: Rep. McKinley, David B. [R-WV-1] · what a sponsor is
  3. What happened next: no floor votes in our records yet. Why?
  4. Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Patients' Access to Treatments Act of 2013

Plain summary

Patients' Access to Treatments Act of 2013 - Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing cost-sharing requirements, including co-payment and co-insurance, applicable to prescription drugs in a specialty drug tier that exceed the dollar amount of cost-sharing requirements applicable to prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier. Defines: (1) "non-preferred brand drug tier" as a category of prescription drugs within a tier in a formulary for which beneficiary cost-sharing is greater than tiers for generic drugs or preferred brand drugs, and that are not included within a specialty drug tier; and (2) "specialty drug tier" as a category of prescription drugs within a tier in a formulary for which beneficiary cost-sharing is greater than tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan's formulary.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Patients' Access to Treatments Act of 2013

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. McKinley, David B. [R-WV-1] · 142 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Shelley Moore Capito (R-WV), Paul Tonko (D-NY), Suzanne Bonamici (D-OR), Chellie Pingree (D-ME), Eleanor Holmes Norton (D-DC), Gwen Moore (D-WI), Edward J. Markey (D-MA), Julia Brownley (D-CA), Peter Welch (D-VT), Mark Takano (D-CA), William R. Keating (D-MA), Sanford D. Bishop, Jr. (D-GA), Mark Pocan (D-WI), Dina Titus (D-NV), Jared Huffman (D-CA), Robert J. Wittman (R-VA), Stephen F. Lynch (D-MA), Betty McCollum (D-MN), James P. McGovern (D-MA), Bennie G. Thompson (D-MS) and 82 more.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Sources

Record fed-us-cong113-hr460 · catalog fed-us-congress-bills-cong113 · updated 2026-11-15 by psicol fed-bills-cong113